OR WAIT null SECS
The Friday 5 from Endocrinology Network is a list composed by the Endocrinology Network editorial staff aimed at highlighting relevant coverage from endocrinology and endocrinology-related fields.
Every Friday, Endocrinology Network provides a curated list of 5 articles focused or related to a particular topic in endocrinology. This week, the Friday 5 from Endocrinology Network highlights the 5 most popular articles from the past week.
Using data from within NHANES from 2011-2018, investigators from Johns Hopkins University provide a comprehensive overview of the use of aspirin for primary and secondary prevention among older patients based on diabetes status.
Data from the REWIND trial suggests men receiving dulaglutide had an 8% lower risk for incident erectile dysfunction than their counterparts who were randomized to placebo therapy.
A look at more than 300 clinical trials examining dietary supplements and alternative therapies for inducing weight loss has returned evidence detailing a lack of high-quality evidence related to the efficacy of these approaches.
Using 24 years of follow-up data from more than 12k adolescents provides insight into the impact of childhood BMI z-scores on risk of adverse health outcomes, including development of diabetes and premature myocardial infarction, in adulthood.
Coverage of the American Diabetes Association's 81st Scientific Sessions (ADA 2021)